Snider NT et al. |
The endocannabinoid anandamide is a substrate for the human polymorphic cytochrome P450 2D6. |
2008 |
J. Pharmacol. Exp. Ther. |
pmid:18698000
|
Moreira FA et al. |
Reduced anxiety-like behaviour induced by genetic and pharmacological inhibition of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) is mediated by CB1 receptors. |
2008 |
Neuropharmacology |
pmid:17709120
|
Kaufmann I et al. |
Anandamide and neutrophil function in patients with fibromyalgia. |
2008 |
Psychoneuroendocrinology |
pmid:18395993
|
Hegde VL et al. |
Attenuation of experimental autoimmune hepatitis by exogenous and endogenous cannabinoids: involvement of regulatory T cells. |
2008 |
Mol. Pharmacol. |
pmid:18388242
|
Solinas M et al. |
The endocannabinoid system in brain reward processes. |
2008 |
Br. J. Pharmacol. |
pmid:18414385
|
Farrell EK and Merkler DJ |
Biosynthesis, degradation and pharmacological importance of the fatty acid amides. |
2008 |
Drug Discov. Today |
pmid:18598910
|
Yao F et al. |
Development of novel tail-modified anandamide analogs. |
2008 |
Bioorg. Med. Chem. Lett. |
pmid:18723350
|
Kase Y et al. |
Removal of 2-arachidonylglycerol by direct hemoperfusion therapy with polymyxin B immobilized fibers benefits patients with septic shock. |
2008 |
Ther Apher Dial |
pmid:18937720
|
Thors L et al. |
Inhibition of fatty acid amide hydrolase by kaempferol and related naturally occurring flavonoids. |
2008 |
Br. J. Pharmacol. |
pmid:18552875
|
Ellgren M et al. |
Dynamic changes of the endogenous cannabinoid and opioid mesocorticolimbic systems during adolescence: THC effects. |
2008 |
Eur Neuropsychopharmacol |
pmid:18674887
|
Fowler CJ and Ghafouri N |
Does the hydrolysis of 2-arachidonoylglycerol regulate its cellular uptake? |
2008 |
Pharmacol. Res. |
pmid:18675915
|
DeMorrow S et al. |
Anandamide inhibits cholangiocyte hyperplastic proliferation via activation of thioredoxin 1/redox factor 1 and AP-1 activation. |
2008 |
Am. J. Physiol. Gastrointest. Liver Physiol. |
pmid:18096608
|
Rubino T et al. |
Role in anxiety behavior of the endocannabinoid system in the prefrontal cortex. |
2008 |
Cereb. Cortex |
pmid:17921459
|
Taylor AH et al. |
The role of the endocannabinoid system in gametogenesis, implantation and early pregnancy. |
2007 Sep-Oct |
Hum. Reprod. Update |
pmid:17584820
|
Sakamoto Y et al. |
Clinical responses and improvement of some laboratory parameters following polymyxin B-immobilized fiber treatment in septic shock. |
2007 Sep-Oct |
ASAIO J. |
pmid:17885340
|
Oka S et al. |
Depolarization-induced rapid generation of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand, in rat brain synaptosomes. |
2007 |
J. Biochem. |
pmid:17339228
|
D'Argenio G et al. |
Overactivity of the intestinal endocannabinoid system in celiac disease and in methotrexate-treated rats. |
2007 |
J. Mol. Med. |
pmid:17396241
|
Holt S et al. |
Inhibition of fatty acid amide hydrolase, a key endocannabinoid metabolizing enzyme, by analogues of ibuprofen and indomethacin. |
2007 |
Eur. J. Pharmacol. |
pmid:17397826
|
Mahler SV et al. |
Endocannabinoid hedonic hotspot for sensory pleasure: anandamide in nucleus accumbens shell enhances 'liking' of a sweet reward. |
2007 |
Neuropsychopharmacology |
pmid:17406653
|
Kopczyńska B |
The contribution of VR1 and CB1 receptors and the role of the afferent vagal pathway in modelling of cardio-respiratory effects of anandamide in rats. |
2007 |
Life Sci. |
pmid:17379256
|
Ferrer B et al. |
Regulation of brain anandamide by acute administration of ethanol. |
2007 |
Biochem. J. |
pmid:17302558
|
Naidu PS et al. |
Evaluation of fatty acid amide hydrolase inhibition in murine models of emotionality. |
2007 |
Psychopharmacology (Berl.) |
pmid:17279376
|
Sun Y et al. |
Cannabinoid activation of PPAR alpha; a novel neuroprotective mechanism. |
2007 |
Br. J. Pharmacol. |
pmid:17906680
|
Rubio M et al. |
Short-term exposure to alcohol in rats affects brain levels of anandamide, other N-acylethanolamines and 2-arachidonoyl-glycerol. |
2007 |
Neurosci. Lett. |
pmid:17574742
|
Ryberg E et al. |
The orphan receptor GPR55 is a novel cannabinoid receptor. |
2007 |
Br. J. Pharmacol. |
pmid:17876302
|
Lam PM et al. |
Activation of recombinant human TRPV1 receptors expressed in SH-SY5Y human neuroblastoma cells increases [Ca(2+)](i), initiates neurotransmitter release and promotes delayed cell death. |
2007 |
J. Neurochem. |
pmid:17442052
|
Mulè F et al. |
Evidence for a modulatory role of cannabinoids on the excitatory NANC neurotransmission in mouse colon. |
2007 |
Pharmacol. Res. |
pmid:17574859
|
Karsak M et al. |
Attenuation of allergic contact dermatitis through the endocannabinoid system. |
2007 |
Science |
pmid:17556587
|
Bátkai S et al. |
Endocannabinoids acting at CB1 receptors mediate the cardiac contractile dysfunction in vivo in cirrhotic rats. |
2007 |
Am. J. Physiol. Heart Circ. Physiol. |
pmid:17557913
|
Köfalvi A et al. |
Anandamide and NADA bi-directionally modulate presynaptic Ca2+ levels and transmitter release in the hippocampus. |
2007 |
Br. J. Pharmacol. |
pmid:17435795
|
Williams J et al. |
Quantitative method for the profiling of the endocannabinoid metabolome by LC-atmospheric pressure chemical ionization-MS. |
2007 |
Anal. Chem. |
pmid:17600384
|
Esposito G et al. |
Opposing control of cannabinoid receptor stimulation on amyloid-beta-induced reactive gliosis: in vitro and in vivo evidence. |
2007 |
J. Pharmacol. Exp. Ther. |
pmid:17545311
|
Karanian DA et al. |
Endocannabinoid enhancement protects against kainic acid-induced seizures and associated brain damage. |
2007 |
J. Pharmacol. Exp. Ther. |
pmid:17545313
|
Duarte CD et al. |
Synthesis, pharmacological evaluation and electrochemical studies of novel 6-nitro-3,4-methylenedioxyphenyl-N-acylhydrazone derivatives: Discovery of LASSBio-881, a new ligand of cannabinoid receptors. |
2007 |
Bioorg. Med. Chem. |
pmid:17275312
|
Lam FF et al. |
Pharmacological characterization of receptor types mediating the dilator action of anandamide on blood vessels of the rat knee joint. |
2007 |
Life Sci. |
pmid:17275857
|
Sharkey KA et al. |
Arvanil, anandamide and N-arachidonoyl-dopamine (NADA) inhibit emesis through cannabinoid CB1 and vanilloid TRPV1 receptors in the ferret. |
2007 |
Eur. J. Neurosci. |
pmid:17459108
|
Coopman K et al. |
Temporal variation in CB2R levels following T lymphocyte activation: evidence that cannabinoids modulate CXCL12-induced chemotaxis. |
2007 |
Int. Immunopharmacol. |
pmid:17276894
|
Shivachar AC |
Cannabinoids inhibit sodium-dependent, high-affinity excitatory amino acid transport in cultured rat cortical astrocytes. |
2007 |
Biochem. Pharmacol. |
pmid:17445778
|
Orliac ML et al. |
Increases in vanilloid TRPV1 receptor protein and CGRP content during endotoxemia in rats. |
2007 |
Eur. J. Pharmacol. |
pmid:17482593
|
Michalski CW et al. |
Cannabinoids ameliorate pain and reduce disease pathology in cerulein-induced acute pancreatitis. |
2007 |
Gastroenterology |
pmid:17484889
|
Ghasemi M et al. |
Role of the nitric oxide pathway and the endocannabinoid system in neurogenic relaxation of corpus cavernosum from biliary cirrhotic rats. |
2007 |
Br. J. Pharmacol. |
pmid:17486141
|
Borsani E et al. |
AM404 decreases Fos-immunoreactivity in the spinal cord in a model of inflammatory pain. |
2007 |
Brain Res. |
pmid:17459353
|
Sit SY et al. |
Novel inhibitors of fatty acid amide hydrolase. |
2007 |
Bioorg. Med. Chem. Lett. |
pmid:17459705
|
Lory P and Chemin J |
Towards the discovery of novel T-type calcium channel blockers. |
2007 |
Expert Opin. Ther. Targets |
pmid:17465728
|
Ryan D et al. |
Interactions of cannabidiol with endocannabinoid signalling in hippocampal tissue. |
2007 |
Eur. J. Neurosci. |
pmid:17419758
|
Gonthier MP et al. |
Identification of endocannabinoids and related compounds in human fat cells. |
2007 |
Obesity (Silver Spring) |
pmid:17426318
|
Raduner S et al. |
Self-assembling cannabinomimetics: supramolecular structures of N-alkyl amides. |
2007 |
J. Nat. Prod. |
pmid:17497806
|
Wang Y and Wang DH |
Neural control of blood pressure: focusing on capsaicin-sensitive sensory nerves. |
2007 |
Cardiovasc Hematol Disord Drug Targets |
pmid:17346127
|
Basavarajappa BS |
Critical enzymes involved in endocannabinoid metabolism. |
2007 |
Protein Pept. Lett. |
pmid:17346227
|
Jia Y and Lee LY |
Role of TRPV receptors in respiratory diseases. |
2007 |
Biochim. Biophys. Acta |
pmid:17346945
|
Solinas M et al. |
Nicotinic facilitation of delta9-tetrahydrocannabinol discrimination involves endogenous anandamide. |
2007 |
J. Pharmacol. Exp. Ther. |
pmid:17351107
|
Centonze D et al. |
The endocannabinoid system is dysregulated in multiple sclerosis and in experimental autoimmune encephalomyelitis. |
2007 |
Brain |
pmid:17626034
|
Spivak CE et al. |
The endocannabinoid anandamide inhibits the function of alpha4beta2 nicotinic acetylcholine receptors. |
2007 |
Mol. Pharmacol. |
pmid:17628012
|
Cippitelli A et al. |
The anandamide transport inhibitor AM404 reduces ethanol self-administration. |
2007 |
Eur. J. Neurosci. |
pmid:17650118
|
Wang H et al. |
Differential regulation of endocannabinoid synthesis and degradation in the uterus during embryo implantation. |
2007 |
Prostaglandins Other Lipid Mediat. |
pmid:17259073
|
Adermark L and Lovinger DM |
Retrograde endocannabinoid signaling at striatal synapses requires a regulated postsynaptic release step. |
2007 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:18077376
|
Lemak MS et al. |
Cannabinoid regulation in identified synapse of terrestrial snail. |
2007 |
Eur. J. Neurosci. |
pmid:18028114
|
Béquet F et al. |
CB1 receptor-mediated control of the release of endocannabinoids (as assessed by microdialysis coupled with LC/MS) in the rat hypothalamus. |
2007 |
Eur. J. Neurosci. |
pmid:18052990
|
Rettori V et al. |
Endocannabinoids in TNF-alpha and ethanol actions. |
2007 |
Neuroimmunomodulation |
pmid:18073513
|
Akerman S et al. |
Cannabinoid (CB1) receptor activation inhibits trigeminovascular neurons. |
2007 |
J. Pharmacol. Exp. Ther. |
pmid:17018694
|
Shimozawa N et al. |
Estrogen and isoflavone attenuate stress-induced gastric mucosal injury by inhibiting decreases in gastric tissue levels of CGRP in ovariectomized rats. |
2007 |
Am. J. Physiol. Gastrointest. Liver Physiol. |
pmid:17023553
|
Vandevoorde S et al. |
Lack of selectivity of URB602 for 2-oleoylglycerol compared to anandamide hydrolysis in vitro. |
2007 |
Br. J. Pharmacol. |
pmid:17143303
|
Peroni RN et al. |
Participation of CGRP and prostanoids in the sex-linked differences of vascular anandamide effects in mesenteric beds of Sprague-Dawley rats. |
2007 |
Eur. J. Pharmacol. |
pmid:17169358
|
Moreira FA et al. |
Anxiolytic-like effect of cannabinoids injected into the rat dorsolateral periaqueductal gray. |
2007 |
Neuropharmacology |
pmid:17156799
|
Jin XH et al. |
Discovery and characterization of a Ca2+-independent phosphatidylethanolamine N-acyltransferase generating the anandamide precursor and its congeners. |
2007 |
J. Biol. Chem. |
pmid:17158102
|
Rossi G et al. |
Follicle-stimulating hormone activates fatty acid amide hydrolase by protein kinase A and aromatase-dependent pathways in mouse primary Sertoli cells. |
2007 |
Endocrinology |
pmid:17110429
|
Yuece B et al. |
Cannabinoid type 1 receptor modulates intestinal propulsion by an attenuation of intestinal motor responses within the myenteric part of the peristaltic reflex. |
2007 |
Neurogastroenterol. Motil. |
pmid:17727394
|
Cross-Mellor SK et al. |
Effects of the FAAH inhibitor, URB597, and anandamide on lithium-induced taste reactivity responses: a measure of nausea in the rat. |
2007 |
Psychopharmacology (Berl.) |
pmid:17111174
|
Ronco AM et al. |
Anandamide inhibits endothelin-1 production by human cultured endothelial cells: a new vascular action of this endocannabinoid. |
2007 |
Pharmacology |
pmid:17114903
|
Bourne C et al. |
Novel, potent THC/anandamide (hybrid) analogs. |
2007 |
Bioorg. Med. Chem. |
pmid:17827022
|
Ho WS and Randall MD |
Endothelium-dependent metabolism by endocannabinoid hydrolases and cyclooxygenases limits vasorelaxation to anandamide and 2-arachidonoylglycerol. |
2007 |
Br. J. Pharmacol. |
pmid:17245358
|
Russo R et al. |
Synergistic antinociception by the cannabinoid receptor agonist anandamide and the PPAR-alpha receptor agonist GW7647. |
2007 |
Eur. J. Pharmacol. |
pmid:17434479
|
Wheal AJ et al. |
Effects of chronic nitric oxide synthase inhibition on the cardiovascular responses to cannabinoids in vivo and in vitro. |
2007 |
Br. J. Pharmacol. |
pmid:17245361
|
Bátkai S et al. |
Decreased age-related cardiac dysfunction, myocardial nitrative stress, inflammatory gene expression, and apoptosis in mice lacking fatty acid amide hydrolase. |
2007 |
Am. J. Physiol. Heart Circ. Physiol. |
pmid:17434980
|
Harada N and Okajima K |
Effect of topical application of capsaicin and its related compounds on dermal insulin-like growth factor-I levels in mice and on facial skin elasticity in humans. |
2007 |
Growth Horm. IGF Res. |
pmid:17307377
|
Romero FA et al. |
Potent and selective alpha-ketoheterocycle-based inhibitors of the anandamide and oleamide catabolizing enzyme, fatty acid amide hydrolase. |
2007 |
J. Med. Chem. |
pmid:17279740
|
McCollum L et al. |
Anandamide-mediated CB1/CB2 cannabinoid receptor--independent nitric oxide production in rabbit aortic endothelial cells. |
2007 |
J. Pharmacol. Exp. Ther. |
pmid:17379772
|
Wang Y et al. |
Endocannabinoid regulates blood pressure via activation of the transient receptor potential vanilloid type 1 in Wistar rats fed a high-salt diet. |
2007 |
J. Pharmacol. Exp. Ther. |
pmid:17308041
|
Snider NT et al. |
Anandamide metabolism by human liver and kidney microsomal cytochrome p450 enzymes to form hydroxyeicosatetraenoic and epoxyeicosatrienoic acid ethanolamides. |
2007 |
J. Pharmacol. Exp. Ther. |
pmid:17272674
|
Matta JA et al. |
TRPV1 is a novel target for omega-3 polyunsaturated fatty acids. |
2007 |
J. Physiol. (Lond.) |
pmid:17038422
|
Solinas M et al. |
The endogenous cannabinoid anandamide produces delta-9-tetrahydrocannabinol-like discriminative and neurochemical effects that are enhanced by inhibition of fatty acid amide hydrolase but not by inhibition of anandamide transport. |
2007 |
J. Pharmacol. Exp. Ther. |
pmid:17210800
|
Gasperi V et al. |
Endocannabinoids in adipocytes during differentiation and their role in glucose uptake. |
2007 |
Cell. Mol. Life Sci. |
pmid:17187172
|
Côté M et al. |
Circulating endocannabinoid levels, abdominal adiposity and related cardiometabolic risk factors in obese men. |
2007 |
Int J Obes (Lond) |
pmid:17224929
|
Smita K et al. |
Anandamide: an update. |
2007 |
Fundam Clin Pharmacol |
pmid:17227440
|
Matas D et al. |
Anandamide protects from low serum-induced apoptosis via its degradation to ethanolamine. |
2007 |
J. Biol. Chem. |
pmid:17227767
|
Wise LE et al. |
Assessment of anandamide's pharmacological effects in mice deficient of both fatty acid amide hydrolase and cannabinoid CB1 receptors. |
2007 |
Eur. J. Pharmacol. |
pmid:17217945
|
Hsu SS et al. |
Anandamide-induced Ca2+ elevation leading to p38 MAPK phosphorylation and subsequent cell death via apoptosis in human osteosarcoma cells. |
2007 |
Toxicology |
pmid:17222495
|
Harada N and Okajima K |
Inhibition of neutrophil activation by lafutidine, an H2-receptor antagonist, through enhancement of sensory neuron activation contributes to the reduction of stress-induced gastric mucosal injury in rats. |
2007 |
Dig. Dis. Sci. |
pmid:17211693
|
Pisanti S et al. |
Antiangiogenic activity of the endocannabinoid anandamide: correlation to its tumor-suppressor efficacy. |
2007 |
J. Cell. Physiol. |
pmid:17192847
|
Ekins S et al. |
Three-dimensional quantitative structure-activity relationship analysis of human CYP51 inhibitors. |
2007 |
Drug Metab. Dispos. |
pmid:17194716
|
Schreiber D et al. |
Determination of anandamide and other fatty acyl ethanolamides in human serum by electrospray tandem mass spectrometry. |
2007 |
Anal. Biochem. |
pmid:17196922
|
Kreutz S et al. |
Cannabinoids and neuronal damage: differential effects of THC, AEA and 2-AG on activated microglial cells and degenerating neurons in excitotoxically lesioned rat organotypic hippocampal slice cultures. |
2007 |
Exp. Neurol. |
pmid:17010339
|
Malfitano AM et al. |
Arvanil and anandamide up-regulate CD36 expression in human peripheral blood mononuclear cells. |
2007 |
Immunol. Lett. |
pmid:17360047
|
Blankman JL et al. |
A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-arachidonoylglycerol. |
2007 |
Chem. Biol. |
pmid:18096503
|
Degenhardt BF et al. |
Role of osteopathic manipulative treatment in altering pain biomarkers: a pilot study. |
2007 |
J Am Osteopath Assoc |
pmid:17908831
|
Xu H et al. |
Functional effects of nonsynonymous polymorphisms in the human TRPV1 gene. |
2007 |
Am. J. Physiol. Renal Physiol. |
pmid:17913835
|
Athanasiou A et al. |
Cannabinoid receptor agonists are mitochondrial inhibitors: a unified hypothesis of how cannabinoids modulate mitochondrial function and induce cell death. |
2007 |
Biochem. Biophys. Res. Commun. |
pmid:17931597
|
Soria-Gómez E et al. |
Pharmacological enhancement of the endocannabinoid system in the nucleus accumbens shell stimulates food intake and increases c-Fos expression in the hypothalamus. |
2007 |
Br. J. Pharmacol. |
pmid:17549045
|
Kracke GR et al. |
The cannabinoid receptor agonists, anandamide and WIN 55,212-2, do not directly affect mu opioid receptors expressed in Xenopus oocytes. |
2007 |
Naunyn Schmiedebergs Arch. Pharmacol. |
pmid:17960365
|
Thomas KC et al. |
Transient receptor potential vanilloid 1 agonists cause endoplasmic reticulum stress and cell death in human lung cells. |
2007 |
J. Pharmacol. Exp. Ther. |
pmid:17332266
|